Influence of environmental temperature on incidence of indinavir-related nephrolithiasis

被引:19
作者
Martínez, E [1 ]
Leguizamón, M [1 ]
Mallolas, J [1 ]
Miró, JM [1 ]
Gatell, JM [1 ]
机构
[1] Hosp Clin Barcelona, Infect Dis Unit, Inst Invest Biomed, Infect Dis Unit, E-08036 Barcelona, Spain
关键词
D O I
10.1086/520226
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed the influence of temperature, humidity, and atmospheric pressure on the 1-year incidence of nephrolithiasis among human immunodeficiency virus type 1-infected patients treated with indinavir. One hundred three patients (13.6%) developed 326 episodes of nephrolithiasis. Eighty-two patients (79.6%) had more than one episode (range, two to seven episodes). The overall incidence ranged from 0 to 10.2 episodes per 100 patients exposed per month. There was a significant correlation between temperature and the overall incidence of nephrolithiasis and the incidence of recurrences but not with the incidence of first episodes. Nephrolithiasis was not related to humidity or atmospheric pressure. Our data support the standard recommendation of drinking at least 1.5 L of water daily to prevent nephrolithiasis in most patients treated with indinavir irrespective of meteorologic factors. However, the risk of nephrolithiasis is higher for a certain subgroup of patients when the environment is hot irrespective of adequate water intake.
引用
收藏
页码:422 / 425
页数:4
相关论文
共 22 条
[1]  
Al-Hadramy Mohamad Salim, 1997, JPMA (Journal of the Pakistan Medical Association), V47, P281
[2]  
Bach MC, 1997, J ACQ IMMUN DEF SYND, V14, P296
[3]  
Bailar J., 1986, Medical uses of statistics
[4]   HOT OCCUPATION AND NEPHROLITHIASIS [J].
BORGHI, L ;
MESCHI, T ;
AMATO, F ;
NOVARINI, A ;
ROMANELLI, A ;
CIGALA, F .
JOURNAL OF UROLOGY, 1993, 150 (06) :1757-1760
[5]   Changes in renal function associated with indinavir [J].
Boubaker, K ;
Sudre, P ;
Bally, F ;
Vogel, G ;
Meuwly, JY ;
Glauser, MP ;
Telenti, A .
AIDS, 1998, 12 (18) :F249-F254
[6]   Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients [J].
Brodie, SB ;
Keller, MJ ;
Ewenstein, BM ;
Sax, PE .
AIDS, 1998, 12 (18) :2433-2437
[7]   Urinary stones in HIV-1-positive patients treated with indinavir [J].
Daudon, M ;
Estepa, L ;
Viard, JP ;
Joly, D ;
Jungers, P .
LANCET, 1997, 349 (9061) :1294-1295
[8]   Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients [J].
Dieleman, JP ;
Gyssens, IC ;
van der Ende, ME ;
de Marie, S ;
Burger, DM .
AIDS, 1999, 13 (04) :473-478
[9]   HIV-protease inhibitors [J].
Flexner, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1281-1292
[10]   PREVENTION OF UROLITHIASIS - EDUCATION TO ADEQUATE FLUID INTAKE IN A NEW TOWN SITUATED IN JUDEAN DESERT MOUNTAINS [J].
FRANK, M ;
DEVRIES, A ;
TIKVA, P .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1966, 13 (05) :625-&